Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01534468 · ClinicalTrials.gov registry record · Phase 1
Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults
A Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT01534468 is a Phase 1 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 45 participants.
The verdict
NCT01534468, a Phase 1 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
H7N7 is one type of influenza virus that may pose a threat to humans if an outbreak occurs. This study will evaluate the safety and immune response to an H7N7 vaccine in people who have previously received a live attenuated influenza vaccine (LAIV) as part of a research study and people who have not previously received a LAIV.
Interventions
- BIOLOGICAL Monovalent Influenza Subvirion Vaccine, H7N7
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01534468
The ClinicalTrials.gov registry entry for NCT01534468 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Monovalent Influenza Subvirion Vaccine, H7N7 is the first listed.
NCT01534468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01534468 about?
NCT01534468 is a clinical study titled "Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults". H7N7 is one type of influenza virus that may pose a threat to humans if an outbreak occurs. This study will evaluate the safety and immune response to an H7N7 vaccine in people who have previously received a live attenuated influenza vaccine (LAIV) as part of a research study and people who have not...
What is the current status of trial NCT01534468?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2012-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01534468?
The interventions under investigation include: Monovalent Influenza Subvirion Vaccine, H7N7 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01534468?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.